Skip to content
Sign in
Health · Global

Contraceptive coil pain led Caroline Bailey to discover 13cm tumour and ovarian cancer, she says

Caroline Bailey says stabbing pain from a contraceptive coil that was pressing against a 13cm tumour prompted her to seek medical help. She was diagnosed with stage three ovarian cancer and, after chemotherapy and surgery at The Christie NHS Foundation Trust, now has no evidence of disease.

AI-assisted synthesis · Based on 4 independent reports from 5 outlets · Full text read from 1 of 4 reportsHow it's made

View timeline · 2 developments
5 outletsLatest reporting 3 min read
Coverage: Center OnlyL 0 · C 4 · R 0 · 1 unrated
Updat3 graphic: Europe
Updat3 graphic · Map data: Natural Earth Natural Earth (public domain)

What happened

Key facts

  • Caroline Bailey is a 54-year-old former childminder who lives in north Wales (per walesonline.co.uk).
  • Bailey started experiencing severe abdominal pain in March 2023 which she initially believed was related to her contraceptive coil (per walesonline.co.uk).
  • Bailey says a large 13cm tumour was pressing against her contraceptive coil and the resulting stabbing pain caused her to seek medical help (per walesonline.co.uk).
  • Bailey said she had to 'crawl' into the GP surgery because the pain was so severe (per walesonline.co.uk, Yahoo, nacionale.com).
  • Bailey was diagnosed with stage three ovarian cancer in June 2023 (per walesonline.co.uk).
  • Bailey now has no evidence of disease following treatment (per walesonline.co.uk, Yahoo, BBC).
  • Bailey has no family history of ovarian cancer, according to her account (per walesonline.co.uk).

The brief

Caroline Bailey, a 54-year-old former childminder from north Wales, says stabbing pain from her contraceptive coil exposed a previously undetected cancer. Bailey told WalesOnline that in March 2023 she began experiencing severe abdominal pain she believed was linked to the coil; she said the pain became so acute she had to crawl into her GP surgery.

After blood tests, Bailey said she was informed her CA125 level was 72 U/ml and was placed on a two-week pathway for further investigation. Bailey said doctors discovered a large tumour measuring 13cm that had been pressing against the coil, and she was diagnosed with stage three ovarian cancer in June 2023.

She described initially being told her bloods were fine at an A&E visit before further follow-up at her GP surgery led to the raised CA125 result and expedited referral. Bailey also said her diagnosis came shortly after her daughter was given the all clear for thyroid cancer.

WalesOnline reports that Bailey feared the prognosis after reading statistics about five-year survival for stage three ovarian cancer, and that the diagnosis forced significant life changes. Bailey recounted both the physical shock of the pain and the emotional strain of confronting the cancer diagnosis while her family had recently faced another cancer scare.

Following diagnosis, Bailey underwent chemotherapy and surgery at The Christie NHS Foundation Trust, WalesOnline says, and she now has no evidence of disease. In describing her treatment pathway, Bailey highlighted the combination of hospital care and oncology services that led to her current status of no evidence of disease.

Bailey told WalesOnline there is no history of ovarian cancer in her family, which underpinned her initial surprise at the diagnosis. Her account, as carried by headlines in Yahoo, Nacionale News and the BBC, frames the contraceptive coil’s role in producing pain that prompted medical review and ultimately the cancer diagnosis.

Her story, as recounted to WalesOnline, follows a sequence from severe pain and an A&E visit to GP follow-up, an elevated CA125 result, urgent referral and the discovery of a 13cm tumour that led to the stage three ovarian cancer diagnosis and subsequent treatment that currently shows no evidence of disease.

Why it matters

  • A named individual, Caroline Bailey, faced immediate physical harm (severe abdominal pain that required her to crawl to a GP) caused by a contraceptive coil pressing against a 13cm tumour, highlighting how device-associated symptoms can reveal serious underlying disease.
  • The documented clinical pathway—elevated CA125 at 72 U/ml, placement on a two-week pathway, and treatment at The Christie NHS Foundation Trust—shows the diagnostic and treatment steps that led to Bailey having no evidence of disease after stage three ovarian cancer.
  • Bailey’s account that there is no family history of ovarian cancer and that her daughter had recently recovered from thyroid cancer underscores the unpredictable presentation of cancer and the potential for screening markers and urgent referral pathways to change outcomes.

What to watch next

  • Whether Caroline Bailey has further follow-up appointments or surveillance at The Christie NHS Foundation Trust as part of her post-treatment care, as implied by her ongoing 'no evidence of disease' status in the article.
  • Whether Bailey’s GP surgery or local NHS services review management or information given to patients with contraceptive coils after her account of initial A&E advice that 'your bloods are fine' prior to later elevated CA125 results.
  • Whether any interviews or statements from The Christie NHS Foundation Trust are published in response to Bailey’s account, given the article attributes her treatment and current status to that institution.

How it's being covered

Coverage analysisShow details
5 source articles · 5 unique outlets · 4 distinct reports
Coverage mix: Center Only· 4 Center
Where the outlets are based: Europe 80% · Global 20%
Coverage mix
Center Only
Left
Center
Right
0 outlets
4 outlets
0 outlets
The marker shows coverage balance: each unique outlet counts once. 1 unrated outlet is not included.
Geography
Where the outlets covering this story are based.
5 unique outletsDominant coverage: Europe
Coverage imbalance
  • Coverage is currently concentrated among Center-rated outlets (4 of 4 rated sources); comparatively few Left or Right-rated outlets have published on the event.
  • Coverage is currently concentrated among outlets based in Europe (4 of 5 geographically-identified sources).
How we measure coverage

How outlets' accounts compare

Updat3 does not yet have enough full reports to compare how outlets framed this story.

Timeline

Dated developments stated by this story's own sources
  1. Bailey started experiencing severe abdominal pain in March 2023 which she initially believed was related to her contraceptive coil.
  2. Bailey was diagnosed with stage three ovarian cancer in June 2023.

How we got here

Immediate backdrop: In 2015 the National Institute for Health and Care Excellence published guideline NG12 (updated 2015) on suspected cancer recognition and referral, which set specific symptom thresholds and urgent referral pathways for possible ovarian cancer in primary care.

Structural roots: The FIGO ovarian cancer staging system revised in 2014 remains the international standard for classifying disease extent and underpins treatment pathways used by NHS cancer centres such as The Christie NHS Foundation Trust, a specialist cancer hospital in Manchester founded in 1901.

Original sources

1 of 5 articles · Global · Show all

Every story links to the reporting it was built from. How we choose sources

Spotted a factual error, a broken link or a misleading summary? Tell us.